Literature DB >> 33771981

Long non-coding RNA ZFAS1 is a major regulator of epithelial-mesenchymal transition through miR-200/ZEB1/E-cadherin, vimentin signaling in colon adenocarcinoma.

Stephen J O'Brien1, Casey Fiechter1, James Burton1, Jacob Hallion1, Mason Paas1, Ankur Patel1, Ajay Patel1, Andre Rochet1, Katharina Scheurlen1, Sarah Gardner1, Maurice Eichenberger1, Harshini Sarojini1, Sudhir Srivastava2,3, Shesh Rai2, Theodore Kalbfleisch4, Hiram C Polk1, Susan Galandiuk5.   

Abstract

Colon adenocarcinoma is a common cause of cancer-related deaths worldwide. Epithelial-mesenchymal transition is a major regulator of cancer metastasis, and increased understanding of this process is essential to improve patient outcomes. Long non-coding RNA (lncRNA) are important regulators of carcinogenesis. To identify lncRNAs associated with colon carcinogenesis, we performed an exploratory differential gene expression analysis comparing paired colon adenocarcinoma and normal colon epithelium using an RNA-sequencing data set. This analysis identified lncRNA ZFAS1 as significantly increased in colon cancer compared to normal colon epithelium. This finding was validated in an institutional cohort using laser capture microdissection. ZFAS1 was also found to be principally located in the cellular cytoplasm. ZFAS1 knockdown was associated with decreased cellular proliferation, migration, and invasion in two colon cancer cell lines (HT29 and SW480). MicroRNA-200b and microRNA-200c (miR-200b and miR-200c) are experimentally validated targets of ZFAS1, and this interaction was confirmed using reciprocal gene knockdown. ZFAS1 knockdown regulated ZEB1 gene expression and downstream targets E-cadherin and vimentin. Knockdown of miR-200b or miR-200c reversed the effect of ZFAS1 knockdown in the ZEB1/E-cadherin, vimentin signaling cascade, and the effects of cellular migration and invasion, but not cellular proliferation. ZFAS1 knockdown was also associated with decreased tumor growth in an in vivo mouse model. These results demonstrate the critical importance of ZFAS1 as a regulator of the miR-200/ZEB1/E-cadherin, vimentin signaling cascade.

Entities:  

Year:  2021        PMID: 33771981      PMCID: PMC7998025          DOI: 10.1038/s41420-021-00427-x

Source DB:  PubMed          Journal:  Cell Death Discov        ISSN: 2058-7716


  38 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR.

Authors:  Carl Robert Rankin; Janet Treger; Emmanuelle Faure-Kumar; Jihane Benhammou; Deborah Anisman-Posner; Alex Edward Bollinger; Charalabos Pothoulakis; David Miguel Padua
Journal:  J Vis Exp       Date:  2019-03-01       Impact factor: 1.355

3.  A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

Authors:  Cameron P Bracken; Philip A Gregory; Natasha Kolesnikoff; Andrew G Bert; Jun Wang; M Frances Shannon; Gregory J Goodall
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

4.  The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Authors:  Jordi Barretina; Giordano Caponigro; Nicolas Stransky; Kavitha Venkatesan; Adam A Margolin; Sungjoon Kim; Christopher J Wilson; Joseph Lehár; Gregory V Kryukov; Dmitriy Sonkin; Anupama Reddy; Manway Liu; Lauren Murray; Michael F Berger; John E Monahan; Paula Morais; Jodi Meltzer; Adam Korejwa; Judit Jané-Valbuena; Felipa A Mapa; Joseph Thibault; Eva Bric-Furlong; Pichai Raman; Aaron Shipway; Ingo H Engels; Jill Cheng; Guoying K Yu; Jianjun Yu; Peter Aspesi; Melanie de Silva; Kalpana Jagtap; Michael D Jones; Li Wang; Charles Hatton; Emanuele Palescandolo; Supriya Gupta; Scott Mahan; Carrie Sougnez; Robert C Onofrio; Ted Liefeld; Laura MacConaill; Wendy Winckler; Michael Reich; Nanxin Li; Jill P Mesirov; Stacey B Gabriel; Gad Getz; Kristin Ardlie; Vivien Chan; Vic E Myer; Barbara L Weber; Jeff Porter; Markus Warmuth; Peter Finan; Jennifer L Harris; Matthew Meyerson; Todd R Golub; Michael P Morrissey; William R Sellers; Robert Schlegel; Levi A Garraway
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

5.  Downregulation of the long non-coding RNA ZFAS1 is associated with cell proliferation, migration and invasion in breast cancer.

Authors:  Shulin Fan; Chunni Fan; Ning Liu; Keke Huang; Xuedong Fang; Keren Wang
Journal:  Mol Med Rep       Date:  2018-03-09       Impact factor: 2.952

Review 6.  Potential clinical application of lncRNAs in non-small cell lung cancer.

Authors:  Tong Lu; Yuanyong Wang; Di Chen; Jia Liu; Wenjie Jiao
Journal:  Onco Targets Ther       Date:  2018-11-13       Impact factor: 4.147

7.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

8.  DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts.

Authors:  Maria D Paraskevopoulou; Ioannis S Vlachos; Dimitra Karagkouni; Georgios Georgakilas; Ilias Kanellos; Thanasis Vergoulis; Konstantinos Zagganas; Panayiotis Tsanakas; Evangelos Floros; Theodore Dalamagas; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2015-11-26       Impact factor: 16.971

9.  Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9.

Authors:  Tao Wang; Sicong Ma; Xingxing Qi; Xiaoyin Tang; Dan Cui; Zhi Wang; Jiachang Chi; Ping Li; Bo Zhai
Journal:  Onco Targets Ther       Date:  2016-08-12       Impact factor: 4.147

10.  Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway.

Authors:  Jianhui Cai; Limin Xia; Jinlei Li; Shichang Ni; Huayu Song; Xiangbin Wu
Journal:  Cancer Res Treat       Date:  2018-04-25       Impact factor: 4.679

View more
  7 in total

Review 1.  Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics.

Authors:  Hyein Jo; Kyeonghee Shim; Dooil Jeoung
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

Review 2.  Long Non-Coding RNAs as Potential Regulators of EMT-Related Transcription Factors in Colorectal Cancer-A Systematic Review and Bioinformatics Analysis.

Authors:  Ana Pavlič; Nina Hauptman; Emanuela Boštjančič; Nina Zidar
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

3.  Upregulated long intergenic non-protein coding RNA 1094 (LINC01094) is linked to poor prognosis and alteration of cell function in colorectal cancer.

Authors:  Guangliang Zhang; Yingjie Gao; Zhen Yu; Hui Su
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  A Novel Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Patients with Papillary Renal Cell Carcinoma.

Authors:  Ruijie Dang; Meiling Jin; Jingzhu Nan; Xuege Jiang; Zheng He; Fang Su; Diangeng Li
Journal:  Int J Gen Med       Date:  2022-01-06

Review 5.  MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets.

Authors:  Brian G Jorgensen; Seungil Ro
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

6.  lncRNA ZFAS1 Positively Facilitates Endothelial Ferroptosis via miR-7-5p/ACSL4 Axis in Diabetic Retinopathy.

Authors:  Yu Liu; Zhengyu Zhang; Jing Yang; Jingfan Wang; Yan Wu; Rongrong Zhu; Qinghuai Liu; Ping Xie
Journal:  Oxid Med Cell Longev       Date:  2022-08-31       Impact factor: 7.310

7.  Differential Expression of Decorin in Metastasising Colorectal Carcinoma Is Regulated by miR-200c and Long Non-Coding RNAs.

Authors:  Margareta Žlajpah; Kristian Urh; Jan Grosek; Nina Zidar; Emanuela Boštjančič
Journal:  Biomedicines       Date:  2022-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.